Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Models of Health Promotion and Illness Prevention I

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2020

Same author

A High-Resolution National-Scale Hydrologic Forecast System from a Global Ensemble Land Surface Model.

Journal of the American Water Resources Association·2019

Same author

TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4 NON-SMALL CELL LUNG CANCER.

Cancer treatment and research communications·2017

Same author

Country Docs With City Technology Can Address Rural Cancer Care Disparities.

Oncology (Williston Park, N.Y.)·2015

Same author

100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.

Journal of the American Academy of Dermatology·2015

Same author

Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.

Annals of surgical oncology·2014

Same journal

The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection.

Journal of oncology practice·2019

Same journal

Oncologic Implications of Chronic Hepatitis C Virus Infection.

Journal of oncology practice·2019

Same journal

Considerations for Long-Term Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and Cancer.

Journal of oncology practice·2019

Same journal

Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.

Journal of oncology practice·2019

Same journal

Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences.

Journal of oncology practice·2019

Same journal

Management of Brain Metastases in Non-Small-Cell Lung Cancer.

Journal of oncology practice·2019

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

A model for rural oncology.

Laurence J Heifetz¹, Scott D Christensen, Ralph W Devere-White

¹Tahoe Forest Cancer Center, Truckee; University of California, Davis Cancer Center, Sacramento, CA.

Journal of Oncology Practice

|September 3, 2011

Summary

This summary is machine-generated.

Developing a sustainable rural oncology program is achievable. The Tahoe Forest Cancer Center model successfully overcame barriers, offering a blueprint for high-quality cancer care in underserved areas.

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Area of Science:

Rural Health
Oncology Program Development
Healthcare Management

Background:

Small rural hospitals face significant challenges in establishing sustainable oncology programs.
Geographic, cultural, and financial barriers impede access to cancer care in rural settings.
Patient and family fears are amplified in remote locations.

Purpose of the Study:

To report on the development and success of a rural oncology program.
To present a sustainable model for high-quality cancer care in a rural community.
To offer a potential framework for other rural healthcare systems.

Main Methods:

Established the Tahoe Forest Cancer Center in 2006.
Focused on addressing common cancer patient and family fears.
Developed a creative academic affiliation.
Integrated the program into the hospital's future strategic focus.

Main Results:

The program became thriving within four years.
Achieved significant community support.
Successfully overcame geographic, cultural, and financial barriers.
Demonstrated a sustainable model for high-quality cancer care.

Conclusions:

A sustainable rural oncology program can be successfully developed.
The Tahoe Forest Cancer Center model provides a viable structure for rural cancer care.
This model may serve as a national template for rural healthcare delivery.